company

Icahn School of Medicine at Mount Sinai

as of 2026-07-01
Monitor thisAsk about this
at a glance
10 trials sponsored · 16 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

16 assets
AripiprazoleOlanzapineQuetiapineRisperidoneZiprasidoneAerobic exerciseBlood samples for whole genomic/transcriptomic sequencingCognitive Remediation TherapyGuanfacineGuanfacine/TenexOvernight polysomnography examinationsPimozideSertindoleStretching and Toning ExerciseUKU Side Effect Rating Scaleisradipine

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Olanzapine
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Ziprasidone
small molecule
drug
Aerobic exercise
BEHAVIORAL
drug
Blood samples for whole genomic/transcriptomic sequencing
OTHER
drug
Cognitive Remediation Therapy
BEHAVIORAL
drug